Neuroendocrine differentiation is a common feature of thymic carcinoma
- PMID: 9737237
- DOI: 10.1097/00000478-199809000-00003
Neuroendocrine differentiation is a common feature of thymic carcinoma
Abstract
Immunohistochemical evidence of neuroendocrine differentiation in the form of reactivity for synaptophysin, neuron-specific enolase, and/or chromogranin was found in 11 of 19 (58%) thymic carcinomas having the typical morphologic features of that tumor type. Four of these 19 cases were studied ultrastructurally, and neuroendocrine-type cytoplasmic dense-core granules were found in two. In contrast, 84 thymomas were negative for these markers, except for a focal immunoreactivity for neuron-specific enolase in areas of medullary differentiation in half of the lymphocyte-rich tumors. The results of this study show that in the thymus, similar to most other organs, neuroendocrine differentiation is not limited to tumors with an identifiable neuroendocrine appearance in hematoxylin-eosin-stained slides, such as carcinoid tumor and small cell carcinoma, but rather that it represents a common event shared by the major types of malignant epithelial tumors of that organ.
Similar articles
-
Neuroendocrine differentiation in thymic epithelial tumors with special reference to thymic carcinoma and atypical thymoma.Hum Pathol. 1998 Apr;29(4):330-8. doi: 10.1016/s0046-8177(98)90112-5. Hum Pathol. 1998. PMID: 9563781
-
Two cases of atypical carcinoid of the thymus.Intern Med. 2000 Oct;39(10):834-8. doi: 10.2169/internalmedicine.39.834. Intern Med. 2000. PMID: 11030210
-
Neuroendocrine differentiation in 32 cases of so-called sclerosing hemangioma of the lung: identified by immunohistochemical and ultrastructural study.Am J Surg Pathol. 1997 Sep;21(9):1013-22. doi: 10.1097/00000478-199709000-00005. Am J Surg Pathol. 1997. PMID: 9298877
-
[Thymomas and thymic carcinomas].Rev Mal Respir. 2010 Dec;27(10):1281-7. doi: 10.1016/j.rmr.2010.08.009. Epub 2010 Nov 18. Rev Mal Respir. 2010. PMID: 21163404 Review. French. No abstract available.
-
Selected markers (chromogranin A, neuron-specific enolase, synaptophysin, protein gene product 9.5) in diagnosis and prognosis of neuroendocrine pulmonary tumours.Pol J Pathol. 2007;58(1):23-33. Pol J Pathol. 2007. PMID: 17585539 Review.
Cited by
-
Thymoma with ganglioneuroblastomatous component: case report.Virchows Arch. 2008 Mar;452(3):319-24. doi: 10.1007/s00428-007-0544-y. Virchows Arch. 2008. PMID: 18094997
-
Thymus neuroendocrine tumors with CTNNB1 gene mutations, disarrayed ß-catenin expression, and dual intra-tumor Ki-67 labeling index compartmentalization challenge the concept of secondary high-grade neuroendocrine tumor: a paradigm shift.Virchows Arch. 2017 Jul;471(1):31-47. doi: 10.1007/s00428-017-2130-2. Epub 2017 Apr 27. Virchows Arch. 2017. PMID: 28451756
-
Neuroendocrine tumors of the thymus and mediastinum.J Thorac Dis. 2017 Nov;9(Suppl 15):S1448-S1457. doi: 10.21037/jtd.2017.02.02. J Thorac Dis. 2017. PMID: 29201448 Free PMC article. Review.
-
Atypical thymoma (WHO B3) with neuroendocrine differentiation: report of a case.Virchows Arch. 2006 Aug;449(2):234-7. doi: 10.1007/s00428-006-0218-1. Epub 2006 May 4. Virchows Arch. 2006. PMID: 16673117
-
Goblet cell carcinoids and other mixed neuroendocrine/nonneuroendocrine neoplasms.Virchows Arch. 2007 Aug;451 Suppl 1:S61-9. doi: 10.1007/s00428-007-0447-y. Epub 2007 Aug 8. Virchows Arch. 2007. PMID: 17684764 Review.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical